|
Research Reviews
Current clinical research studies may one day help in the
diagnosis, prevention and treatment of vascular
diseases. Studies listed in this section must answer an
important scientific question about vascular disease and
must be approved by an Institutional Review Board. (By
listing these studies, the Vascular Disease Foundation is
not endorsing the studies, the study center, the study
sponsor, or the treatment.)
- In a study entitled "Evaluation of Large Vessel and
Microvascular Disease with Contrast Enhanced
Ultrasound of Leg Skeletal Muscle," the University of
Virginia School of Medicine will study whether an
ultrasound of the calf can be used to detect impaired
blood flow due to PAD. Ultrasound results will be
compared to other noninvasive tests such as ABI and
pulse volume recordings, as well as angiograms.
Contact: Lisa Womack at 434-982-4008 or email: lms5a@virginia.edu
- The Division of Cardiovascular Medicine at Stanford
University is investigating the "NO PAIN Study: A
Double Blind, Placebo-Controlled Study of L-Arginine
in the Treatment of PAD." The NO PAIN
study will determine if administration of L-arginine can improve blood flow in people with PAD and
thereby improve walking distance and quality of life.
L-arginine is a semi-essential amino acid found in our
diet. The body converts L-arginine into nitric oxide
(NO), which is a powerful vasodilator, i.e., it increases
blood flow. To date, the study has found that people
with vascular disease, or with risk factors for vascular
disease, produce less NO. Study investigators have
also found that they can increase NO synthesis in
these individuals by administering L-arginine. Now
they are trying to determine if, by improving vessel
relaxation, they can improve blood flow in the legs
and improve walking distance in people with PAD.
Contact: Kathi Kari or Gina Droll (para Español) at 650-723-4064.
For more information on these and other clinical studies,
visit the new Clinical Trials Resource Center on the
Foundation's web site at www.vdf.org.
The Vascular Disease Foundation and any sponsors disclaim, either explicitly
or implicitly, that the drug, biologic or device listed here is safe or
effective for the purposes under investigation, or that the test article is
known to be equivalent or superior to any other drug, biologic or device.
Additionally, no claims are made regarding the scientific utility and conduct
of clinical trials or research studies listed.
|